ML20217C320

Rev 1 to Security Dept Procedure IS-AC-00018, Drug & Alcohol Testing Process

ML20217C320
Person / Time
Site:	Davis Besse
Issue date:	06/27/1990
From:	Leny L CENTERIOR ENERGY
To:
Shared Package
ML20217C290	List: ML20217C284 ML20217C300 ML20217C307 ML20217C314 ML20217C320 ML20217C328 ML20217C340 ML20217C348 ML20217C357 ML20217C366 ML20217C381 ML20217C394 ML20217C400
References
IS-AC-00018, IS-AC-18, NUDOCS 9107150220
Download: ML20217C320 (52)

Text

. _ . . _ . _ . _ . _ _ _ . _ _ . . _ . _ . . _ _ _ _ _ . . . . . _ _ . _ _ _ _ . -

6 ,

IS-AC-00018, REVISION 01 C90-6465 COMPLETE "INFORMATION ONLY" ll,'":' 71 T.O;;, .

y noor;,c,):'9708;

. H hy .;.q g_

f: Dft

b t i

IS-AC-00018, REVISION 01 C90-6465 COMPLETE 4

"INFORMATION ONLY" JJ g ' .

I, t.ooo(I) 3 y,{

UTIfi

wm _L ' . . . . . . . . -

, _ I l & 9o-&%5 cca w uo SECTION 1 10 ENTITY eaoseuo a uo ; i.  ; u~ca.4A m.

... eum caam. ; t wmw, m-u,c ae , ,.. . L.*.S. .*.A,W., .WP. .ht *r*so" ko ;"'*t * ' c are _._ ~.:w.w . p<% . . . c . .<me acr=c, o.

<eu 'o

. { .s } l [*l CeWW ~

• %at mt- _._._

bidtmn ) Ie 2N oI W1 aoe:c.as c.4ssigt 54 rv ar.tra ara.*i:'

~LMM

• t g oc Ar,r crets ese ws c.au: at

..C.....sa .., p. 04 : s sa._..-

.. Rvre *.e a 4 taa ,y <taa '/O .f6, % N

• M. .

.a _ *e - - - -

nn4 6. u- , , 90 f c. 9 g-wspwro-Q y 5 a

e 'l

wws:

NLE _ pi,8Ma Ataan L, aMw

• • aw. num .wr.cc:r..;4cs SECTION 2 OUALIFIED REVIEW C Y$ $ NO i . u n , i. y;.#m

[ *( $ K hQ

% 4 ,ystta.,p M p m .

AaO40 % E a) 20wAt:

i

1. f cA*t PaLCEW,*t W%bem sa t Y . !,f rw') L td 4 *

• e YAMA / 91*k l0

(/ SECTION 3. CROSS.OlSCIPUNARY REVIEW DUE:

% %.ago ag awg g.tp ;a3 cac w%c La*g us.sv 4 a4 Atrt3 ese3 c .%Et %L ;a's

' "h ' '] L, N X bb'Oh ol Al

[ [T1.$ Z [ .

O  :  ;

C G-=m wqn g"[.f 0 0__

w .

,- y L - '

W L -'

SECTION 4. ATTACHMENTS vt3 Na couArtD AND Anacr4o vtn 44 vg3 44

! 2:CC.WEkt th'T=F ACE WOf*3 MEET C V AUCAW Cr4C@ST i  ; couwatst vra.acA'ow sowwamy t; p- sAsrN aretw  : $ .E400. MANUAL 00N8 Suetch a;aw w y, (D.tC4AA ntmFCAttoN cs(04sf ic ; occvutut arview satra C K 14FtTy rvawatcN  ; 3 affSEC C)CES MFlaENCtl .St

%A#G A(v Civi4 1 00Nc AMNc(

= 's o*ca OA *E

- SECTibN 5 TEMPORARY APPROVAL p, -r .,~~~u s, --a y, i

l SECTION 6. CONCURRENCE / FINAL APPROVAL

&*iRQjy i**] . L .Q \ \

p/A 1 **

• ac ryrv

, c.rs

, p lfy y ,

!c4 2.<'f[m.iu4a6= xle  !

/

SECTION 7. TRAINING / PROCEDURE EFFECTIVITY tuu% %x.am ,,,.suca rc~ ,ca .c raawa

%VIS C NO

' rai+~o couwc8 ccs a m. .

I cart

=cC4'wt0 f t',gg

. ora ~ ,..c . . u, :. r.m .

,m s v. - c.1

}_ l _ x ^' A M - / . -

( i

.----..es we y -- -,w.-r-y r q n eg.m-e_,-y,---..-mi, e .-emve,--,wt- w-e- -'v---eie. -g m6e- y sW->-%e1- y,r- w r-e.a++w-'W*h"

, T' 4 8 ~

No IS- AC-06018 SoCurity Dopartmont E6oo180N Procedure n a visio N 0; .

sussect .... i o, tapsctsvtDAte 3, INefi At to av ~

Drug and Alcohol Testing #

Process svetassoas A. R. Schumaker 4*eaovio a v io.....a owai " ~

IS-AC-00018 Revision 00 N/A l

Prepared Byt t vh dm Date 6/> 9/96 '

r i

P Sponsor i etm .

en ,m Date k /' 7 7/9D Supe ~r. visor - Access Control'

~

/

f ,. -

/

WM. GmMg b../ f/b/dp Approved By: .bf.'" E _ [- 27-[M Date '

Manh. gar - Industrial Security

[ V. '? j f

'"7; amw (i , , s uob O N L ,3 Safety Related

____X_ Quality Related Non-Quality Related

se nn .

PAGE i R(yl$ ION PROC (DURE NUMBER

DAVIS BESSE ADMINISTRATIVE PROCEDURE Drug and Alcohol Testing Process 2 01 IS-AC-00019 i l

i U ST OF EFFECTIVE PAGES i,

I Pace Chanao tio. Pace Chanao fio. Pace Chance !Jo. ! j 1 22 C-1 43 i 2 .. .C- 1 23 44  !

1 i

3 C-1 24 45 1 1

4__ _C-1 25 C-1 46 5 26 C-1 47 6 27 C-1 48 l 4

7 28 49

I 8 29 C-1 50 C-1 i 9 30 51 C-1 10 31 C-1 i 11 _ _3 2_ ,

12 33 13 34

(

14 35 i

36 l 15 16 C-1 37 17 38 18 39 C-1 .  ;

19 40 l l 20 41 j ,

t i I

i j -

i i

. . . . = . . _ _- -- __ _ .-.

. s DAV.2 8 ESSE ADMINISTRATIVE PROCEDURE PAGE RE VISION P30CEDUAE NUMBER I

I Drug and Alcohol Testing Process i 3 01 l IS-AC-00018 -

TABLE OF CONTENTS Pace i'

1.0 PURPOSE .......................................... 4 2.0 3 COPE / APPLICABILITY .............................. 4

3.0 REFERENCES

4 4.0 DEFINITIONS ...................................... 4 5.0 RESPONSIBILITIES ................................. 9 6.0 PROCEDURE ........................................ 10 6.1 General Requirements ........................ 10 6.2 Personnel Training and Qualification ........ 11 6.3 Collection Site Requirements . .............. 13 6.4 Pre-Test Processing ........................ 14 6.5 Drug Test Processing ................... 17 6.6 Observed Eampling ........................... ..... 22 6.7 Shipment .................................... 23 6.8 Storage ..................................... 24 6.9 Alcohol Testing Process ..................... 25 6.10 Review of Results ...........................

6.11 Quality Control .............................

23 33 6.12 Unsatisfactory Laboratory Performance Testing ..................................... 34 6.13 Receipt of False Positive Errors From the Laboratory .................................. 35 6.14 Additional Laboratory Reporting Requirements ................................ 36 6.15 Methods For Follow-Up Testing ............... 38 7.0 RECORDS .......................................... 39 ATTACHMENT 1: Collection Site Log ......,.............. 40 ATTACHMENT 2: Individual Specimen Collection Documentation ........................... 41 ATTACHMENT 3 Fitness For Duty Authorization .......... 43 ATTACHMENT 4: Notification of Random Drug Testing ..... 45 ATTACHMENT 5: Drug Testing Custody & Control Form ..... 46 ATTACHMENT 6: Low Specific Gravities & Creatinine  !

Concentrations Log ...................... 47 ATTACHMENT 7: Temperature Record Log .................. 48 4

ATTACHMENT 8: Blind Samples ........................... 49 ATTACHMENT 9: Notification of Breath Alcohol Testing .. 50 C-1!

COMMITMENTS............................................. 51 r

l

g..-.

davis BESSE ADMINISTRATIVE PROCEDURE PAGE PEvts oN l PRottbust NUMeta Drug and Alcohol Testing Process 4 01 IS-AC-00018 1.0 EURPOSE .

1 The purpose of this procedure is to establish a drug and alcohol l testing program which satisfies the requirements of 10CTR26,  !

Fitness For Duty Programs. This procedure implements NG-IS-00004,  !

fitness for Duty Program, i 2.0 SCOPE / APPLICABILITY This procedure applies to all Security and Health Center l l personnel involved in the drug and alcohol testing program.  !

3.0 PEFERENCES l 3.1 Develocrental 3

3.1.1 10CFR26, Fitness For Duty Programs 3.2 Jnolenentation i l

3.2 1 Medical Review Officer Manual (NIDA)  ! ,

3.2.2 NG-IS-00004, Fitness for Duty Program j 3.2.3 NG-IM-00106 (NG-PS-00106), Nuclear Records  !

C-1 Management 3.2.4 NG-IM-00112, Correspondence Control  ;

3.2.5 NC-NL-00807, Regulatory Reports C-1lr 3.2.6 IS-DP-00518, Reporting Requirements 3.2.7 IS-DP-00100, BAC Examinations 3.2.8 IS-AC-00516, Unescorted Access Requirements I i

3.2.9 IS-AC-00017, Denied Access List Control l 4.0 DEFINITIONS 4.1 ABERRANT BEHAVIOP - Aberrant behavior is any significant change in the ir.dividual's nnrmal or usual functioning  !

behavior in terms of work-related activities and  !

interaction with other individuals in the work place.

Aberrant behavior may be caused by stress, fatigue, other psychological problems and the itse of drugs or alcohol. l I

l l

i 1

l ---

DAVIS:BESSE ADMINISTRATIVE PROCEDURE PAGE f.EVISloN PIoCEDURE NbMBER Drug and Alcohol Tceting procons 5 01 IS-AC-00018 4.2 ALIQUOT - A portion of a specimen used for testing.

4.3 BLOOD ALCOHOL CONCENTRATION (BAC) - Blood alcohol concentration is a measure of the mass of alcohol in a +

volume of blood such that an individual with 100 mg of alcohol per 100 .nl of blood has a BAC of 0.10 percent.

Blood alcohol concentration can be measured directly from blood alcoholorinderived from a measure of the concentration of breath specimen.

4.4 ,

CHAIN-OF-CUSTODY - procedures to account for the integrity i of each speciman by tracking specimen handling and storage from the point of collection to final disposition.

4.5 CCLLECTION SITE - A place designated by Company Management where individuals present themselves for the purpose of providing a specimen of urine, breath, or blood to be analyzed for the presence of drugs tr alcohol.

4.6 COLLECTION SITE PERSONNEL - personnel who instruct and assist individuals at a collection Lite and who receive 3nd make an initial examination of the specimen (s) provided by those individuals.

J 4.7 COMPANY PERSONNEL - Those personnel assigned to work at Davis -Besse who are employed by Centerior Energy Corporatica or its subsidiaries.

4.8 CONFIRMATORY TEST - A second analytical procedure to identify the presence of a specific drug or drug metabolite which is independent of the initial screening test and which uses a different technique and chemical principle from that of the initial test in order to ensure reliability and accuracy. (At this time Gas Chromatography / Mass Spectrometry (GC/MS) is the onl method for cocaine, marijuana, opiates,y authorized confirmatory 1

amphetamines, phencyclidine). For dctermining blood alcohol levels, a confirmatory test means a second test using another breath  ;

i alcohol analysis device. Further confirmation upon demand j shall be by Gas Chromatography analysis of blood.

i 4.9 CONFIRMED POSITIVE TEST - The result of a confirmatory test that has established the presence of drugs, drug ,

I metabolites, or alcohol in a specimen at or above the cut-off level, and that has been deemed positive by the Medical Review Officer (MRO) after evaluation. A confirmed positive i test for alcohol can also be obtained as a result of a t confirmation analysis without of MRO bloodevaluation.

alcohol levels with a second breath j

1 se tm .

PAGE PROCf DUKE NUMBER l davis.8 ESSE ADMINISTRATIVE PROCEDURE REVtSION - i Drug and Alcohol Testing Process 6 01 IS-AC-00018 i 4.10 CONTRACT PERSONNEL - Those personnel assigned to work at Davis-Besse who are not employed by Centerior Corporation or its subsidiaries.

4.11 CUT-OFF LEVEL - The value set for designating a test cer at as positive.

Marijuana Metabolites ................... 50 ng/ml and

................... 100 ng/ml Cocaine-Metabolites ..................... 300 ng/ml ,

Opiate Metabolites ...................... 300 ng/mi l Phencyclidne ........................... 25 ng/ml  !

Amphetamines ............................ 1000 ng/ml l Alcohol ................................ 0.04% BAC -

l Confirmatory test cut-off levelst l Marijuana ............................... 15 ng/ml ,

Cocaine Metabolites ..................... 150 ng/ml l Opiates: j Morphine ............................ 300 ng/ml i Codeine ............................ 300 ng/mi  !

Phencyclidine ........................... 25 ng/ml  !

Amphetamines l Amphetamines ........................ 500 ng/ml l Metaphetamine ....................... 500 ng/ml Alcohol ................................ 0.04% BAC l 4.12 EVIDENTUARY QUALITY BLOOD ALCOHOL CONCENTRATION ANALYSIS l DEVICE,(BAC) - Breath alcohol analysis device-of a brand and model that conforms to National Highway Traffic Safety e Administration (NMTSA) standards (49FR48855) and the requirements of the Ohio Revised Code. i 4.13 FAILURE / REFUSAL TO COOPERATE - A refusal by an individual to j coope. rate witu the urine collection and/or breath analysis i process by: refusing to provide a complete specimen within the allotted time, complete paperwork, initial specimen labels, or refusing to follow instructions given by Health Center Personnel.

{

4.14 FITNESS FOR DUTY -(FFD) - Reasonable assurance that an individual will perform his or her duties in a reliable and i trustworthy manner. t 4.15 FOLLOW-UP TEST - Chemical testing at unannounced intervals, to ensure that an individual is maintaining abstinence from drug and/or alcohol abuse.

._ .__ _ __ _ . _ _ _ _ _ _ _ _ - _ . -- _ _ _ _ ____. _ _ ._. _ . . . _ _ . _ . . _ . . . ~

. . .= . - .

w

. s=

DAVIS BESSE ADMINCTRATIVE PROCEDURE PAGE PAoCEDutt NUMBE A l AEvisioN Drug cnd Alcohol Tcating Praccoo 7 01 IS-AC-00018 4.16 DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS)/ NATIONAL i INSTITUTE ON DRUG ABUSE (NIDA) CERTIFIED LABORATORY - A urine and blood testing laboratory that maintains certification by the National Institute on Drug Abuse to perform drug testing under the Department of Health and Human Services.

4.17 ILLEGAL DRUGS - Those drugs included in schedules I througn V of the Controlled Substance Act, but not when used 4 pursuant to a valid prescription or when used as otherwise authorized by law.

4.18 INITIAL PRESUMPTIVE POSITIVE TEST - The results of a confirmatory test that has established the presence of illegal drugs which have not been reviewed by the MRO.

4.19 MEDICAL REVIEW OFFICER (MRO) - A licensed physician responsible for receiving laboratory results generated by the DBNPS drug testing program who has knowledge of substance abuse disorders and has appropriate medical training to interpret and evaluate an individual's positive i

test result together with his or her medical history and any other relevant biomedical information.

4.20 PERMANENT RECORD BOOK - A permanent bound book in which identifying data on each specimen collected at a collection site are permanently recorded in the sequence collected.

4.21 PRIVACY - Allowing an individual privacy when providing a urine specimen, unless reason to believe exists that the individual may alter or substitute the specimen.

4.22 RANDOM TEST - A system of unannounced chemical tests administered in a random manner to a group so that each person within that group hr.s an equal probability of selection.

4.23 REASON TO BELIEVE - Beljef that a particular individual may alter or substitute the urine specimen.

4.24 SPLIT SAMPLE - A portion of a urine specimen that may be stored by the Health Center to be tested in the event of I appeal.

- s,--n

s q m. ,

r:GE Revision P octovns Nuvata DAVIS 8 ESSE ADMINISTRATlW PROCEDURE Drug and Alcohol Testing Process 8 01 IS-AC-60018 I

1 4.25 SUITABLE I!iQUIRY - A best-effort verification through a maximum 5 year history, but not less than 3 years, to ascertain if a person was, in the past, testod positive for illegal drugs, subject to an Employee Assistance Program (EAP) (except self-referral), or made ineligible for activities, or denied unescorted access to a nuclear power plant in accordance with a Fitness for Duty (FFD) policy.

i I

l i

l l

- = - - _- , _ _ , , , . _ .

a DAVIS >SESSE ADMINISTRATIVE PROCEDURE PAGE REvislON PAoCEDUKE N' UMBER Drug and Alcohol Tooting Procons- 9 01 IS-AC-00018 5.0 RESPONSIBILITIES 5.1 SPECIFIC TITLES 5.1.1 Medical Review Officer 5.1.2 Supervisor-Medical Services 5.1.3 Supervisor - Access control 5.1.4 Supervisor-Security Shif t 5.2 ORGANIZATIONS 5.2.1 Health Center 5.2.2 Access Control J 5.2.3 Nuclear Security 4

5.3 GENERIC TITLES 5.3.1 Health Center Personnel j_

5.3.2 Access Control Personnel l

-l i

i a

i i

,,_.oy_p,a,msqw-,e++--wm m---?-*m-2 e^ "TT?"N--- '" "

DAVIS 8tlSSE ADMINISTkATIVE PRbCEDURE PAGL r.tvlSloN COCEDUIE NUMBEb Drug cnd Alcohol Tosting Proccos 10 01 IS-AC-00018 6.0 PROCEDURE l UOTE 6.1 l l

l Infornation concerning the drug and alcohol I testing ia confidantial and snall not be l disclosed to persons other than the subject l individual, his/her representative, or to those l personnel who have a need to have access to the l information to perforn assigned duties. No l l individual authorized to have access to this l infotmation may disc 1cse this information to l personnel who do not have a need to know. l 6.1 General _Reauirements 6.1.1 All urine specimens and blood samples shall be tested by laboratories certified by the National Institute on Drug Abuse (NIDA).

6.1.2 Specimens collected as required by this procedure ,

shall not be used to conduct any other analysis or j test without the permission of the tested i individual.

6.1.3 During pre-access, post accident, periodic physicals, for-cause, random, and follow-up drug testing, urine specimens shall be tested fort

a. Cocaine

b. Marijuana

c. opiates  !

d. Amphetamines ,

e. Phencyclidine.

6.1.4 For-causa testing or analysis of any urine specimen suspected of being adulterated or diluted through  ;

l hydration or other means may be tested for any illegal drug.

6.1.5 Supervisors, co-workers, and relatives of the individual being tested shall not perform any collection, assessment, or evaluation procedures.

l l

40 rt a ,

PAGE F.EVISION PAOCEDUKE NUMBER

' DAVIS >SESSE ADMINISTRAT1VE PROCEDURE l

Drug and Alcohol Testing Process 11 01 IS-AC-00018 '

l NOTE _6.1.6 l

-l Initially, these requirements may be waived if an l individual currently holds or has held a valid unescorted access authorization at DBNPS within 365 1 days, 6.1.6 -Prior to assignment the MRO, the alternate MRO, l Access Control Personnel involved in the selection and notification process,. Health Center Personnel j ,

involved in the collection process, those  !

individuals acting as escorts to Magruder' Hospital l l for fitness for duty testing, Supervisorsasecurity 'j Shift, BAC operators and Senior BAC operators ,

shall:

a. Couplete a psychological evaluation

b. Appropriate background checks. ,

I

c. Be subject to continual behavioral observation.

6.1.7 Substeps 6.1.6.a-c shall be updated once every three years. ,

i 6.2 Personnel _Trainina_and_oualification l t

16.2.1 The Medical Review officer shall ensure individuala l assigned as Health-Center personnel receive training, prior'to assignment, on:

1

a. 10CFR26 Appendix A, IS-AC-00018, and NG-IS- l 00004. i

1. -Training on these documents shall be required reading.

b. The performance of drug and alcohol testing in accordance with this procedure.

1. Proficiency. in the performance of drug and alcohol testing shall be documented as part of the Personnel Training Package.

I t

{-

. - - . _ _ _ . _ - , _ . _ _ _ . . _ . _ , .._____u... _ _ . . - _ . . _ .. _ ,_. - ,, - . . . ,

PAGE REVISION PROCEDUKE NUMBER I DAVi$.8ISSE ADMINISTRATIV8 PROCEDURE Drug and Alcohol Tooting Procsas 12 01 IS-AC-00018 6.2.2 The Medical Review Officer shall ensure individuals assigned as Health Center personnel receive l training, prior to assignment, which e.mphasize:

l -

a. Maintaining the integrity of the specimen collection.and transfer process,

b. Assuring the tested individual's privacy and  ;

modesty.

c. Avoiding any conduct or remarks which may be construed as accusatorial or inappropriate.

6.2.3 The Medical Review Officer shall ensure his alternate receives training in the following documents:

i ,

a. 10CFR26, Appendix A l 1

b. NG-IS-00004  !

I

c. IS-AC-00018 l

d. Medical Review Officers Manual as prepared by NIDA.  ;

i l

FOTE_6.2.4 l Personnel Training packages shall be documented 3 and retained in accordance with NG-IM-00119.  ;

- ......................-_. j 6.2.4 The Medical Review Of ficer or Supervisor-Medical j ,

Services shall ensure that training required by l

'this procedure is completed and. documented in j Personnel Training Packages. l .

l

.6.2.5 Continuing training shall consist of required  !

reading to revisions of NG-IS-00004, and.

IS-AC-00018.

! i l

_ _ . - . . _ _ . . ,.. ._,__ _ _ . . .. . _ . _ _ _ , . _ _ _ _ _ . . ~ . . , . , _ , _ _

____-..._.__________.._._m - _ _ _ . _ . _ .

DAVl3 SESSE ADMIMSTRATIVE PROCEDURE PAGE REVISION P:t0CEDURE N' UMBER Drug cnd . Alcohol Tcoting Process 13 01 IS-AC-00018 I

6.2.6 A medical professional, technologist, or_ technician licensed, or otherwise approved to practice in a local hospi' il, may serve as a collection site person by either

a. Complying with the requirements of this procedure, }'

2B $

b. - Being observed through the entire collection j process by an individual familiar.with this l procedure _who meets the requirements of step i 6.1.6. 1 I~

6.3 Collection _ Site _Recuirenents l NOTE _6.3.1 l l l The Personnel Processing Facility (PPF) may be used I as a collection site for. confirmatory BAC testing i and_for-cause BAC testing when Health Center j ,

personnel are not available.

j 6.3.1 The designated. collection site at Davis-Besse shall be the Health Center.

6.3.2 Unauthorized personnel shall not be permitted in  !

the collection site where specimens are collected '

and stored, unless:

-l NOTE _6.3.2.a l 4

A listing of authorized personnel-is; posted'in the Health Center.

a. ._They are escorted by an authorized person. i AEQ Logged on Attachment 1, Collection Site Log.

b.

-6.3.3 To deter the dilution of urine specimens at the Health-Center, Health Center personnel-shall: l

a. . Place bluing agents 11n toilet tanks such that F the reservoir of water in the toilet bowl i remains blue. j i

4

, yy+ = m ,-- veg -,-~..w., ,+,,[,,r-e,--or--w..ww.m.---w_,m..,---,_ _.-em_-,-.m_.~-..

- -.......+,.----.m.,-..,-,4

a-' Avis.BCSE A MIN 5TRATWE PROCEDURE PAGE r,[yl5loN KoCEDU7E NW9E A Drug cnd Alcohol Tooting Proccus 14 01 IS-AC-00018

b. Ensure there is no other source of water in the enclosure where urination occurs.

j c. If another source of water exists, ensure the source is necured or monitored.

6.1.4 If the Health Center is unavailable for use as a collection site and a drug test is required, Health Canter Personnel shc.1 use an on-site or off-site l restroom as follows:

a. Secure and post the restroom against access to >

other than those associated with the tenting l process.

b. If possible, place a toilet bluing agent in the toilet bowl and any accessible toilet tank.  ;

c. If no bluing agent is available to deter specimen dilution, instruct the individual '

being tested not to flush the toilet until the j specimen is collected.

. l

d. Ensure an individual of the same gender {

accompanies the individual being tested l j into the restroom but remains outside the stall. ~

t

e. After tne specimen has been collected, GQ IQ '

subsection 6.5.9 to continue processing the  !

sample.

6.4 Pre-Tent _Processinc

6. .

When an individual arrives at the collection site for drug or alcohol testing, Health Center l personnel shall:

I

a. Initiate Attachment 2, Individual Specimen Collection Documentation. This form shall be  ;

used as a checklist to ensure all steps or actions are completed during the testing '.

l process.

b. Positively identify the individual as the individual to be tested using either:

1. Photo identification RB

2. Identification by Company Supervisor.

l l

1 w

- . - . . _ - .- . - - . . . - - . - - _ . - - . - . - . . - - _ _ . - - . . . - _ - - _ . . _ _ - . . . . ~

- so nn , ,

PAGE QEts510N PQOCEDUCE NUMBER DAVIS SESSE ADMINISTRATIVE PROCEDURE

-Drug and' Alcohol Testing Process 15 01 IS-AC-00018

c. If the individual identity can not be I established:

1. The test shall not be conducted.

2. Notify Access Control to determine I appropriate action. I l

d. Record results of 6.4.1.b or e in I.D. check l l area in Permanent Record Book.  ! ,

I l '

e. Instruct the individual being tested to complete j Attachment 3, Fitness For Duty Authorization. ,

]

l NOTE _6.4.1.f l l l Random' tenting includes drug and alcohol testing. l

f. If the test is a random selections  ;

1. The individual's_ Supervisor shall inform -

i him or her when to report to the Health i Center for the random test.

2. At the Health Center Attachment 1,  !

Notification of Random Testing, is collected from the individual.

3. After reporting to the Health Center at the  ; ,

appointed time,_and a urine sample cannot be provided, the individual is allowod two (2) hours _(from the time of notification i- ,

to report), to provide the specimen. j

4. If the two hour time limit has elapsed, l notify Access Control. {_;

5. Conduct alcohol testing in accordance with i section 6.9, Alcohol Testing Process.  ;

i

g. Instruct the individual being tested to j identify _ prescription medications and over-the.-  ;

counter medications used within the previous 30 j days on Attachment 3, Fitness For Duty [

Authorization. l l '

I i

8 a nn ,

DAVIS 8 ESSE ADMINISTRATIVE PROCEDURE PAGE ' QEvisioN EQoCEDukE NUMBER Drug und Alcohol Testing Process 16 01 IS-AC-00018 i

l'

h. Reaffirm individual has listed all prescription medication taken within previous 30 days. I J

l NOTE: 6.4.1.1 l only medication that may result in a positive I l l drug test shall be subject to verification by I l bringing proscription bottles or a letter from l prescribing physician to the Health Cantor, unless l l otherwise deemed unnecessary by the MRO. l j

i. Verify prescription medications by either:

1. Visual inspection of tha prescription bottle QB  !

2. Receipt of letter from the individual's prescribing physician, j I

j. Upon verification of prescription medications as i

described in step 6.4.1.1, annotate the following information on Attachment 3, Fitness  !

For Duty Authorizaclon next to too prescribed i medication i

1. Pharmacy name i 2. Date prescribed

3. Prescribing physician i

4. Prescription number I

k. For drug testing, complete the identification l label that is affixed to the specimon container by filling in the individual's C-1l l

name and date.

1

1. Affix a label from the Drug Testing custody and Control Form, Attachment 5, containing the specimen identification number, to the side

, of the specimen container. C-1 '

l l

tem ,

DAYlS BESSE ADMINISTRATIVE PROCEDUHE PAG ( QEV!$loN PQoCEDVPE NUMBEQ Drug and Alcohol Testing Process 17 01 IS-AC-00018 I  !

m. Complete the following information in the  !

permanent record book:

1. Requisition Number

2. Tested individual's name

3. Tested individual's social security number  !

4. If applicable, tested individual's i protected area badge number. j

n. If the individual requires drug and alcohol testing, go to Section 6.5, Drug Test Processing. ,

o. If the individual requires only a breath alcohol analysis (For-cause testing for alcohol or call- +

in only), go to Section 6.9, Alcohol Testing Process.

6.4.2 If at any time during the pre-test or testing '

process, an individual refuses to cooperate, Health Center personnel shall:

a. Immediately notify Access Control.

b. Document non-cooperation in Permanent Record '

Book and on Attachment 5.

6.5 D rua_Te st Processinc 6.5.1 To the maximum extent possible, Health Center l personnel shall keep the individual's specimen containers in sight before and after the specimen is  !

provided.

l i

i

{

manna _ "

l

. .. - . . , .- n-, , . = - - . . - . . . - . . ~ . . . . . - . _ . . ~ . . - . + . - . -

60ft?% _

PAGE MvtS89N FGOCEDur E NUMBER DAVi$ BESSE ADMINISTRATIVE PROCEDURE Drug-and Alcohol Testing Process i 18 01 IS-AC-00013 6.5.2 Health Center personnel shall instruct the j individusi to:

I

a. Remove any unnecessary outer garments such as a coat or jacket which may conceal items or aubstances that could be used to adulterate the

• pecimen.

1

b. Request the individual to empty pockets and l place wallet and contents of pockets in to i storage box.

c. Lock-the storage box and allow the individual to take box into the toilet stall. (Key will  !

remain with Health Center Personnel). l l

i

d. Wash and dry his or her hands, with water, but no soap,-prior to urination. l

6.5.3 After the individual's hands are washed prior to ,

urination, Health Center personnel shall ensure thel- )

individual:

a. . Romains in the presence of the colleation site '

person.

b. Does not have access to any water teuntain, laucet, soap dispenser, cleaning agent, or any l L other materials which could be used to l-adulterate the specimen.

6.5.4 Unless there is reason to believe that the individual may alter the specimen to be provided, the Health-Center person shall allow the individuall to provide-the-urine specimen in the privacy of a ,

stall or other partitioned area which allows  ;

privacy. l

[ 6.5.5 If there is reason to believe that the individual

-may alter the specimen, the Health Center person l L shall go to Section 6.6,-observed Sampling.

6.5.6 If a Health Center person leaves the collection l ,

v site momentarily after collecting the specimen from p the individual, he or she shall onsure the specimen is secured,' labeled, sealed, and initialed by the individual providing the specimen prior to leaving.

l.

L l

0*

W DAVIS,BESSE ADkNYTR flVE PROCEDURE. PAGE I REytSION .M'OCEDUT,E fiUMBER '

Drug :end . Alcohol Tooting 'procesc ' 19 01 IS-AC-00018 6.5.7 If a Health Center person _ leaves the collection- I site for an extended period of time, he or she shalll ensure the specimens are packaged for shipment prior to leaving.

6.5.8 -The Health Center-person shall note any unusual behavior or appearance in the permanent record book l i

ar.d on Attachment 5.

l t

____________________ l l NOTE _6.5.9 j l

l Urine specimens may only be provided in the I containers received from the NIDA approved .

i l laboratory.

1 [

6.5.9 After the specimen is provided, Health Center l personnel shall:

a. Instruct.the individual to hand the container I to:the Health Center person as soon as-the { ,

specimen is obtained. '

'b. Within four minutes of urination, measure the temperature of the specimen and record the i temperature in the permanent record book and on i Attachment 5.

I

1. If the temperature of the specimen is }

outside range of:34.4 to 37 degrees centigrade (or 94 to 98.6 degrees .;

Fahrenheit), reason to believe that the i

sample has been. adulterated exists. EQ IQ '

Section 6.6, Observed Sampling.

c. Allow the individual to wash his or-her hands and flush the toilet.

d.- ' Inspect the-specimen for color and signs of contamination.

i

1. If any unusual findings are noted, record the findings in the= permanent record book and go to Section-6.6, Observed Sampling. l l

2. Specimens suspected of being adulterated l should be forwarded to the lab for analysis  !

along with the observed sample. l

^

davis tiSSE ADMIN:3TRATIVE PROCEDURE- PAGE' 8;EVISloN ' P?.oCEDURE NUMBEM Drug and' Alcohol'Tosting'Procons 2C 01 IS-AC-00018

e. Detarmine-that the-urine-specimen contains an adequate sample amount as determined by_the [

laboratory performing the analysis.

1. It an adequate sample has not been provided, an additional sample shall be -)

collected in a separate _ container to reach the total amount required by the laboratory and processed in accordance with steps 6.5.9.a through 6.5.9.d.

2. The individual may be given a_ reasonable amount of liquid to drink'for this purpote.

3. The individual shall be requested to remain at the collection site until an adequate I specimen is provided. .

I l_

4. If the individual can not provide an  !  !

adequate sample within the allotted two j l' l hours, notify Access Control. l

f. Pour half of the urine specimen into another NIDA approved container and securely close bothl containers.

I f

g. Place a tamper-resistant label over each i

. container. '

-1.- Ensure that the tamper-resistant label is I-secured to.the lid and both sides of container. i s i

.2. Do not place the tamper-resistant label over the identification label on the side of the specimen _ container. -

1

h. i Instruct the individual to initial and date the appropriate side of the tamper-resistant label and initial-the identification label.that is i affixed to-the side of-the container. '

l

1. Sign and date tamper-resistant label.in-appropriate place. [

L

j. . Instruct the individual to complete the i-

" employee information" section of Attachment-5. '

1 l

l

DAVIS BESSE ADMINISTRATIVE PROCEDURE PAGE 7,Evt3 ton ' PAoCEDUT.E'NUMBEA

{

Drug cnd Alcohol Tcating Process 21 01 IS AC-00018 j

k. Instruct the individual to read the verification Statement on the Drug Testing l Custody and Control Form, Attachment 3, and sign to verify specimen taken is the individual's. ,

i

1. Place aliquot in tamper-resistant bag, seal bag,  !

sign and date the bag in the appropriate space.  !

m. l Instruct individual to initial and date the bag i in the appropriate space,

n. Enter date and time in permanent record book.

o. Initiate chain-of-custody section of tne Attachment 5 and document:

1. Specimen collector's printed name and  !

signature

2. Date ,

3. Time

4. Condit!in of specimen (e.g., temperature, any obaerved discrepancies)  ;

p. When all blanks have been completed: I

1. Remove parts 3 through 6.

2. Fold and place parts 1 and 2 in the other pocket of the tamper-resistant bag. i

3. Place-parts 3 and 6 with the individual's l medical records.

4. Give part 4 to the individual.

5. Fold and attach part 5 to the split sample l with a rubber band. 1

q. Instruct the individual to sign the permanent i

record book.

r. Sign the permanent record book.

s. If a breath alcohol analysis is required,  !

QQ IQ Section 6.9, Alcohol Testing Process. '

l i

1

PAGE ' REvtsloN PXoCEDURE NUMBER DAVIS.8$SSE ADMINISTRATIVE PROCEDURE Drug and Alcohol Testing Procons 22 01 IS-AC-00018 l

t. If specimens are prepared for shipment within six hours, go to_Section 6.7, Shipment. l 3

u. If specimens a'Je not prepared for shipment I '

within six hours, go to Section 6.8, Storage.

6.6 Observed Sarolina I i

6.6.1 If there is reason to believe that a specimen may be  !

adulterated, the Health Center shall notify Access l  ;

Control and the MRO.

6.6.2 Access Control and/or the MRO should determine C-1l l if an observed specimen collection is required. ,

The critaria listed may be used to determine l whether or not to observe: C-1l I

a. The individual has presenLed a specimen that ,

falls outside the temperature range of 34.4 to l l 37 degrees centigrade or 94 to 98.6 degrees  !

Fahrenheit or the oral temperature does not ,

i equal or exceed that of the specimen,

1. If the individual volunteers a measurement l of oral temperature by sterile thermometer an observed specimen collection may not i be required. C-1

b. The previous specimen provided by the individual l (i.e., on a previous occasion) was determined by ,

the laboratory to have a specific gravity of +

less than 1.003 or a creatinine concentration ,

below .2g/L. ,

c. The collection site person observes conduct l clearly and unequivocally indicating an attempt to adulterate the sample (e.g., substitute urine i in plain view, blue dye in specimen presented, etc.).

t 6.6.3 Health Center Personnel shall:

a. Record test results with specific gravities ,

less than 1.003 or creatinine concentrations 1 ,

below .29/L on Attachment 6, Low Specific  !

Gravities and Creatinine Concentrations Log. I

b. Consult the Log before conducting future tests.

l-I l

l l

l

DAVIS 5 ESSE ADMINISTRAT!VE PROCEDURE PAGE ' CEV'StoN PQoCEDUQE NdMBER Drugiand! Alcohol Testing Process 23 01 'IS-AC-00018

c. Notify Access control of the previous _results prior to conducting another test.

6.'6.4 Ti an1 observed specimen collection is warranted,

Health Center Personnel shall ensuret - l-1

a. An individual of the same gender accompanies l l the tested individual into the specimen l-collection area.

I

b. The witnessing individual observes the specimen j being provided. j

c. Log, in=the permanent record book in the comments section next to the test entry, that ,

the sample collection was " observed". j

d. The suspected adulterated. sample and the-  ! I observed sample are forwarded to the laboratory ,

for analysis.

6.6.5 After the observed sample is collected, the Health ,

Center shall-go to step 6.5.9 to continue processing-the specimen.

6.7 Shiement 6.7.1 Health Center personnel shall ship specimens to thel '

drug laboratory as follows:

a. . Ensure that the-specimen courier signs-Attachment-5 when the custody of the samples have been transferred. 4 b.-- Ensure that Attachment-5 documentation is  !

attached to each-container sealed 1for shipment,

c. Place the specimens in containers; designed to  ;

minimize the possibility'of damage during shipment (e.g., specimen boxes, padded mailers, i-or bulk shipping containers with that {-

capability). l-

d. Securely seal the container to eliminate.the-possibility of-undetected tampering.

e. Sign and-date the label sealing the container.

4 9

i-

-- . - .. - ~ . - . ~ _ . - . - - - - . ...._._.. .. _,_.,__ ___, ,__ __ , , , _ _

wee.w wwe. mumeswaltv41 ave rHUGkDUHg PAGE ' REVI5ibb MOCEDUM NUMBER Drug.cnd Alcohol TestingfProcess '24 01 IS-AC-00018 6.7.2 Upon-notification'from the1 drug testing laboratory that a-: specimen appears to have been tampered with, the-Medical. Review Officerishall:

a.

Make the determination z to either discard or analyze the specimen as the situation warrants. :i

b. Order another specimen taken, c..

Notify Supervisor _ Access _ Control or designee.

6.7.3 The Supervisor - Access Control shall make the determination whether to begin an investigation. '

6.8 Storace 6.8.1 Health Center personnel shall ensure:

]

a. :That specimens not shipped within six hours and any. retained split samples are placed in secure refrigerators or freezers, i

b.

Refrigeration-temperature does not exceed 6 -

degrees. centigrade or 42.8 degrees Fahrenheit.

c.

This temperature shall be. recorded-on a daily 1 basis on-Attachment 7, Temperature Record Log.

d. FreezerL(long-term storage) temperature does not

[

exceed ~20 degrees--centigrade /-4 degrees Fahrenheit.- ,'

e.  :

-This-temperature shall be recorded on a daily basis-on Attachment-7,--Temperatura-Record Log, l

i' f.

~ Emergency: power equipmentais.available:in case of prolonged power outages.  ;

' ~

~

'6.8.2.

In the event of a refrigeration-problem, Health Center personnel shall-immediately notify 1 Maintenance Services for repair.- l l- 6.8.3 Health center. personnel shall transfer split  !

samples =toLlong-term secured. storage by the end of:.l l

i

'l the work day, }

i I

i l-  !

[-

l.

l.

l i

5.

..; c . _ _ . - . . - - . . . _ , . . -

UAVC Ct.bSE ADMINISTRATIVE P.',0CEDURE PAGE REVistoN j PCOCEDURE' NUMBER '

Drug and Alcohol Testing Process 25 01

, l IS-AC-00018 6.B.4 Upon notification from the Medical Review Of ficer that a specimen has tested negative, Health Center l personnel sample.

may discard the stored portion of the I

I NOTE 6.9 l

l Security may perform alcohol testing in a for-cause testing situation outside of normal Medical l _

Service working hours in accordance with IS-DP-l 00100, BAC Examinations. -

6.9 Alcohol Testina Process

---

..____ ..__.._l 6.9.1 Health Center personnel shall test individuals }

l requiring breath alcohol analysis using an evidentiary follows:

quality breath analysis device as a.

If the individual indicates use or ingestion of' mouth alcohol (e.g., mouth wash,C-lij breath ingestedfresheners) or other substances are (e.~. eating, smoking, regurgitation of stomach contents from vomiting or burping),

observe testing. the individual 20 minutes before j C-1l b.

If the individual indicates that no source of mouth alcohol or any other substances have l ,

been ingested within the previous 20 minutes, have him/her complete Attachment 9, ,

Notification of Breath Alcohol Testing, and proceed with the tasting. C-1 c.

Check back of the Alco-Sensor III for temperature, d.

Press " read" button to be sure it reads .000

e. Press set button. i

f. Attach mouthpiece. I i

g.  !

Instruct blow intothe the individual mouthpiece.to take a breath and '

j

h. Near the end of the individual's expiration  ! I depress " read button".  !

i.

Record the number reading in the and Alco-Senser permanent record book.III machine j

y, . s a DAVIS 8 ESSE ADMINISTRATIVE PROCEDURE PAGE REVISION PAOCEDURE NUMBER Druc and Alcohol Testing Process 26 01 IS-AC-00018 l

j. Wait at least 2 minutes but no more than 10  ;

minutes and repeat test.  !

k. Record resuits in the Permanent R9 cord Book.

l NOTE: 6.9.1 1 l l The test results shall be considered valid if the i  !

result of each test is within plus or minus ten  ;  :

l percent of the average of the two tests. l  !

1. Verify that the test is valid and document in .

the permanent record book. j l n. If the test results are not valid, the breath tests shall be repeated using a different l evidentiary quality breath alcohol analysis  ;

device until test results are valid.

n. If the results of the first valid test indicate l less than 0.01 percent blood alcohol j concentration, instruct the individual to return  ;

to work,

o. If the results of the tests indicate a blood alcohol concentration of 0.01 percent or j greater, and there was not a 20 minute waiting period before the test, retest the individual l after the 20 minute observation period in

! accordance with c thru m above. C-1 l p. If the second valid blood alcohol analysis indicates blood alcohol concentration of 0.01 l percent or greater, notify the Supervisor- C-1 Security Shift. 1 i

l l

==

DAVIS BESSE ADMINiaTRATIVE PROCEDURE 'PAGE REVISloN j PAOCEDURE NUMBER i

Drug and Alcohol Testing Process 27 01 lIS-AC-0001a 6.9.2 Upon being notified of an individual with a blood alcohol concentration of greater than .01 C-1 percent, the Supervisor-Security Shift shall:

a. Ensure the individual is escorted to the Personnel Processing Facility (PPF) .

b. Conduct a confirmatory blood alcohol analysis in accordance with IS-DP-00100, BAC Examinations.

C-1 6.9.3 During normal Health Center working hours, Health Center personnel shall draw a blood sample for blood alcohol concentration measurement when requested by an individual testing positive (0.04 percent or greater when reporting for work). This I request shall be made immediately.

6.9.4 If the individual requests blood to be drawn, Health Center personnel shall:

{

a. Cleanse skin with povidone-iodine. C-1l

b. Collect blood in the gray top vacuum tube,

c. Label tube with individual's name and date.

d.

Instruct the individual to initial and date thel appropriate side of the tamper-resistant labe. !

and initial the identification label that is {

affixed to the side of the container. t 6.9.5 In the absence of a voluntary. blood test the second positive breath test shall be considered a confirmed positive.

6.9.6 If confirmation of a positive blood alcohol concentration analysis is requested outside of normal Health Center working hours, Security shall ensure the individual is escorted to Magruder Hospital-to have a blood sample drawn in accordance with NG-IS-00004, Fitness For Duty Program.

etnn '

PAGE REVISION PAoCEDURE NUMBE A DAVIS BESSE ADMINISTRATIVE PROCEDURE Drug and Alcohol Testing Process 28 01 IS-AC-00018 l

6.10 Review of_Results 6.10.1 The Medical Review Officer shall:

a. Be notified of all drug test results,

b. Instruct Health Center Personnel to destroy the split sample when a negative report is received from the laboratory. l

c. Notify Access Control of all negative results.  ;

d. Certify all initial presumptive positive drug j l test results as confirmed positive or negative. j  !

1. Negative results shall be initialed by the MRO and forwarded to the Health Center for  !

inclusion in the individual's medical '

file.

2. Positive results shall carefully be  !

reviewed by the MRO before being certified  ;

as positive. l

e. The MRO shall call the Health center in order l to review medical records that have been made j available by the tested individual when a confirmed positive test may have resulted from legally prescribed medication.

f. Only consider the results of tests obtained, l stored or processed in accordance with this procedure.

6.10.2 Upon notification of unacceptable drug test results from the Laboratory, the MRO shall call the ,

individual's supervisor to schedule a meeting with l the individual and MRO.

6.10.3 The individual's Supervisor shall accompany him or her to the Health Center.

6.10.4 Upon arrival at the Health Center, the Nurse shall:

a. Ensure the individual's Supervisor is present

b. Positively identify the ir.dividual

. . . -_ . .. . _. _ - _ ~ _ _ _ _ _ _ _ _ . _ - . _ . . _.-._ _ __ , _ . _ ,

DAVISc8 ESSE ADMINISTRATIVE PROCEDUkE'. PAGE '%

REVISto PROCEDURE $ UMBER .

d' -

Drug'and1 Alcohol Testing Process 29 01 IS-AC-00018 t

.l NOTE 6.10.4.c =}~

No other' individuals shall be in the same room when-the conversation is taking place.

c .- Connect the individual with the MRO. '

t J- 6.10.5 Prior to certifying ar. initial presumptive positive i drug test result as confirmed positive and within ten working days of result receipt, the MRO shall:

_l UOTE 6.10.5.a l ,

l This meeting may be conducted by telephone l-  ;

provided the involved individual is outside the  !

-Protected Area while the call is taking place and l- e the interview is not for opiate use.

i

a. Document a-good faith effort-to give the  !

individual-an opportunity to discuss the test I results.

1. I

. Documentation of the good faith offert i or opiate exam should be on the Test '

Record / Result from the Laboratory,

b. Conduct the interview with the individual in a-  !

confidential-manner,

c. If the interview'is being conducted for opiate-  !

use then GQ IQ-subsection 6.10.6.

d. Ensure the discussion with the involved , l individual. examines-alternate medical i  !

explanations for the positive test. The MRO I may_ review the individual's medical history or-  !

review any other relevant biomedical factors, i a

e. Determine whether there is clinical evidence, in l addition to the urine test,;of unauthorized use of any commonly-prescribed or commonly included in over-the-counter preparations (e.g. g3 benzodiazepines in the first case and C-1!

barbituates in the second case).

1

.l

1 i l i

- -, -- , , .. , - . , - . n .,-...-_.,v.,.,,,,,,.,.i--,---w,,-

..o..

PAGE- pgylstr)N GQoCEDUQE NUMBER DAVIS SESSE ADMINISTRATIVE PROCEDURE _ -

Drug _and Alcohol Testing Process.

L

-30 01 IS-AC-00018-f.. Determine whether or not the results are acceptable or unacceptable,

g. Upon1 conclusion of the interview with the individual, instruct the individual to have their Supervisor Pick-up the telephone, t

6.10.6 Before-the MRO verifies a confirmed positive result and the licensee takes action for opiates, he or she shall determine that there is: clinical evidence, in addition to the urine test, of unauthorized use of any opium, opiate, or. opium derivative (e.g.

morphine, codeine).

a. Clinical signs of abuse include:

1. Recent needle tracks

2. Behavioral signs of acute opiate intoxication or withdrawl.

3.- Psychological signs of acute opiate intoxication or withdrawl.

b. If the GC/MS confirmation testing for opiates confirms the presence of 6-monacety1 morphine the clinicalLaigns of abuse are not a requirement.  !

i 6.10.7 If results are determined to=be acceptable by the l MRO, he shall notify the individual's Supervisor  !

to release him or her to return to work.  !

-6.10.8 If results are determined-to be unacceptable by the f; iMRO, he shall notify the-individual's Supervisor and the Supervisor-Access Control. { j t

l 6.10.9 -Supervisor - Access Control shall notify the l Supervisor-Security shift l

6.10.10-The individual shall be escorted to the-Supervisor l

- Access control or his designee, j

-6.10.11 The Supervisor - Access Control or his designee shall:

a .- ' Deny the individual site access.in accordance-  !

with-NG-IS-00004, Fitness for Duty Program, Section-6.8, Illegal Drug Related Sanctions and IS-AC-00017, Denied Access List Control.

t i

I I

' DAVIS B SSE ADMiNisTRAilVE PROCEDUnt:

Pact AEVIStoN P90CEDURE NUMBER i Drug and<Alechol Testing Process l 31  ! 01 l IS-AC-00018

b. Meet with the individual to discuss the appeal process and actions required for reinstatement.

6.10.12 Supervisor-Security Shift shall:

a. Recover assigned keys

b. Remove the individual's Protected and Vital Area badge from the Access area

c. Determine reportability in accordance with IS-DP-00518.

6.10.13 Supervisor - Access Control or his designee shall: l

a. Initiate the notification call tree

b. Notify the EAP Coordinator, if applicable.

l NOTE 6.10.13.c  !

A union representative will be provided upon request of the individual.

c. Set-up an interview with Industrial Security Investigations and the individual.

} NOTE 6.10.14 A second analysis request applies only to drug tests.

6.10.14 If the individual requests a second analysis, the Health Center Personnel shall: C-1l

a. Conplete appropriate laboratory forms for the split sample according to guidelines provided with each requisition. C-1

b. Results are requested from an alternate lab.

c. The affected individual is notified to be present when Health Center personnel prepare l the split sample for shipment.

d. If the presence of drugs are not detected go to section 6.12, Unsatisfactory Laboratory Testing.

____ ____ _ _ _ _,______ - _ ________ _ __ _ _ _ _ _ ~

DAV15:8 ESSE ADMINISTRATIVE PftoCEDURE PAGE ' REVISION - PROCCOURE NUMotn -

Drug _and Alcohol Testing Process- 32 01 IS-AC-00018-6.10.15 If a question should arise as to the accuracy or validity-of a.' positive test result only the.MRO  ;

shall' order a reanalysis'of the original sample. )

1 6.10.16. Reanalysis tests are only authorized at DHHS i certified Laboratories. H 6.10.17 The MRO shall report the test result to the licensee as_ negative if he or she determines:

a. There is a legitimate medical explanation for j the positive test result.  ;-

b. Use of the substance identified, through testing  ;

in the manner and at the dosage prescribed, does I not reflect a lack of reliability.

l

c. It is unlikely to create on-the-job impairment.

6.10.18 The MRO may determine that the result is . _

scientifically insufficient'for further action and declare-the test specimen negative based on:

a. Review of inspection reports,

b. Quality control data.

i

c. Multiple samples. l 1

d._ Other pertinent results.

6.10.19 In this situation, the MRO may requestIthat i reanalysis be. performed by the same laboratory or, j that; an aliquot of the original : specimen be sent for i reanalysis to an alternste laboratory __which is  !

certified in accordance with the DHHS Guidelines. l i 1

-6.10.20 The Licensee's testing facility and the DHHS- l l certified _ laboratory shall assist in this review-  ;

process as requested'by the MRO.  !

6.10.21' Individuals responsible for the day-to-day [

management of the licensee's test facility or other j individuals who are forensic toxicologists or who have1 equivalent forensic experience in urine drug-  ;

testing, shall provide specific consultation as

required by the licensee.

L i I

DAVIS SESSE ADMINISTRATIVE PROCEDURE PAGE REVISION >

PXOCEOUSE NUMT,,ER * ]

'E Drug andiAlcohol-;Tosting Process 13 01 l IS-AC-00018 6.10.22 -any Thenegative Licensee'findings shall maintainbasedrecordson scientific that a .imu# r't e insufficiency and sha ll make them'available ce rie NRC on request. Personal _ identifying informatt 1 in such reports shall not be included.

6.10.23 The MRO may use the_ Medical Review Officer.Msnual published by the U.S. Department of Health and Human Services, D2blic Health Service, Alcohol, Drug Abuse, and Mtntal Health Administ 'on, for. i additional rets*ence in reviewing .tive drug test results.

6.10.24 The Medical Review Officer shall maintain records that summarize any negative findings based on scientific insufficiency or alternate medical factors.

a. These records shall be maintained by the MRO for a period of five (5) years. ,

P 16 . 1 1 Oualitv_ Control 6.11.1 Haalth Center arsonnel shall-submit blind l

performance samples to the drug-analysis laboratories as follows:

l NOTE: 6.11.1.a l DBNPS and.PNPP are considered a single licensee for the purpose of! blind sample testing.

a. During-the initial 190-day period of-the f).tness i l,

for duty drug _ testing program for each- pla nt, submit blind performance specimens of at-least i

50-percent of the. total number of samples

-submitted up to a maximum of 250 samples, and

b. Thereafter a minimum of 10 percent of all' l samples to a maximum of 125 samples per quarter.

c. Approximately 80 percent of the blind  !

i l

performance samples submitted shall be certified to contain no drugs. l i

~ _ - - . . _,.,-.,-r _ , _ . ,- _ .,,,y- n , - - . _ . - . . ,

sq im PAGE Pivl5 6 N PAoCEDURE NUMCER 6 AVIS BESSE ASMINISTRATIVS PROCEDURE Drug and Alcohol Testing Process 34 01 IS-AC-00018 .__

d. The remaining 20 percent of the blind performance samples shall be certified spiked positive only with those drugs for which the Company tests,

e. Spiked blind performance samples shall be evenly  ;

distributed across the drug types tested by the j company. j

f. Records of blind performance samples submitted shall be maintained on Attachment 8, Blind Samples.

6.12 Unsatisfactory _ Laboratory _Perfornance_Testina j 6.12.1 Should unsatisf actory performance testing be i detected the MRO shall inform the Supervisor -

Access Control.

6.12.2 When notified by the MRO of unsatisfactory performance testing by the laboratory, the ,

i Supervisor - Access Control shall notify the Manager-Industrial Security and initiate an i investigation.  !

6.12.3 Based on the findings of the investigation, the laboratory shall take action to correct the cause of the unsatisfactory performance testing.

6.12.4 The investigation shall document the findings and corrective action taken by the laboratory.

6.12.5 The individual responsible for the day-to-day management of the DHHS certified laboratory shall j sign and date the investigative and corrective action report, j i

6.12.6 Supervisor - Access Control shall forward the report to Nuclear Licensing.

! 6.12.7 Nuclear Licensing shall process the report I according to NG-NL-00807, Regulatory Reports and forward to the NRC within 30 days of the signature l by the management of the DHHS certified laboratory.

i l

. . . - --. . _ - - ~ - . - - . - . - . - - -_ - . . . - ~ - - - -

DAVIS SESSF ADMINISTRADVE PROCEDUftE !PAGE RE"tStoN PQoCEDURE NUMBEQ -

Drug and Alcohol Testing Process 35 01 IS-AC-00018 6.13 Recelot_of_ False _ Positive _ Errors _From_the_ Laboratory i

6.13.1 -Should a false positive error occur, on a blind test specimen, and the error is determined to be an administrative error (clerical, sample mix-up, . i etc.), the MRO shall immediately notify the Supervisor -Access Control, or designee. y 6.13.2 The NRC shall be notified in accordance with IS-DP-00518, Reporting Requirements, whenever a false i positive error occurs on a blind performance test -!

specimen and the error is determined to be an administrative error.

q 6.13.3 MRO or designee, shall require the laboratory to  ;

take corrective action to minimize future errors up i to'and including review and reanalysis of previously run specimens.  :

6.13.4 Should a-false positive error occur that is  !

determined to be~ technical or methodological the MRO, or designee shall ensure the following:.  ;

a. Immediately notify the Supervisor - Access Control,

b. Request laboratory quality control data from the-batch of specimens which included the false positive.

c. Require a retest of all specimens analyzed-positive for that drug or metabolite from the &

time of final resolution of the error,-to the time of the last satisfactory performance test.

I

d. . Retesting shall be accompanied by a signed  ;

statement of docun.entation from the individual responsible for-the day-to-day management of thi j laboratory testing program.

6.13.5 )GRO may. require an unannounced on-site review of the  !

laboratory, which may be conducted during.any' hours i

of operation.

l 6.13.6 .MRO, may request Supervisor - Access Control or the

-Quality Assurance Director, to conduct audits in l addition to the requirements in 6.12.4 above. j l i

-i

+

i

--J

sp an .

PAGE REVISION DCOCEDUCE NUMBEQ CAVIS 8F.SSE ADMINISTRATIV5 PROCEDURE Drug and Alcohol Testing Process 36 01 IS-AC-00018 6.14 Additional _Laboratorv_Recortino_Reauirements 6.14.1 After receiving laboratory results, the MRO or designee shall ensure the following:

a. DHHS-certified lab reported test results within{

5 working days after receipt of the specimens,

b. The test results were reviewed and certified for accuracy by the responsible laboratory individual (i.e. Scientific Director, Lab  :

Director, or other delegated personnel).  !

I

c. Laboratory upon request, provided quantization j of test results.

l

d. Results are transmitted either by teleprinter, l

• facsimile, computer, courier or U.S. mail.

l l e. Transmittal of results was done in a manner designed to ensure confidentiality of the information. l

f. Results were not provided verbally by telephone, j l

g. The laboratory sent a certified copy of the l original chain-of-custody form signed by the +

l individual responsible for the day-to-day  !

management of the lab, or the individual responsible for attesting to the validity of the 4 test reports.

l h. A copy or the test report is received.

6.14.2 Should any question arise as to the accuracy or validity of a positive test result, only the Medical l

Review Officer is authorized to order a reanalysis

of the original sample.

l 6.14.3 The Medical Review Officer may request that reanalysis be performed by the same laboratory, or that an aliquot of the original specimen, be sent for reanalysis to an alternate laboratory which is l certified in accordance with DHHS Guidelines. l l

l

- - . _ _ _ . --- m._ . .-.. _._ .. . . . . _, - . _ . . . _

DAVIS-SESSE ADMINISTRATIVE PROCEDURE- PAGE= AEVISION 'PROCEDUAE PIUMBER ,

DrugLand Alcoho1I Testing Process 37 011 IS-AC-00018

.6.14.4 The MROlor designee shall ensure that the laboratory (s) provides a monthly statistical summary of urinalysis and blood testing not;more than 14 calendar days after the end of the month covered by j

.the-summary._ The summary shall contain the following information:

l

a. Initial testing:

'1. Number of specimens samples received.

2. Number of specimens reported out. ,

I

3. Number of specimens screened positive, and for what drug-l '

i

b. Confirmatory Testing

1. Number of urine specimens and blood samples received for confirmation. i e.- .- r of specimens' confirmed positive for i eacn drug tested and for each blood sample ,

confirmed positive for blood alcohol  !

concentration, i i ,

c. . Cut-off levels on the DHHS certification l guidelines and-DBNPS cut-off levels, <

6.14.5 Upon receipt of the statistical summary, the MRO or designee should review the information for accuracy as compared with Health Center records. -

6,14.6- IfLany discrepancies are identified, the MRO or i designee shall follow-up to resolve them -; ,

accordingly.  !

6 . 1 4 ,'7 Health Center Personnel-shall utilize the {

monthly statistical. summary to provide information  ;

'to the Supervisor - Access control for completion of the Fitness-For-Duty-Program Performance Data i

Report.

l ]

l l

~

l w -u-m--- y ,-- -- -

isan .

PAGE Revision PROCEDURE NUMBER DAVIS BESSE ADMINISTRATIVE PROCEDURE l- Drug and Alcohol Testing Process 38 01 IS-AC-00018 6.15 Methods Fce_ Follow-Uo_Testina 6.15.1 Unannounced follow-up tests shall be given at least ,

once every month for four months and at least once l every three months for the next two years and eight months after unesecrted access is reinstated to  !

i verify continued abstinence from proscribed substancas.

6.15.2 Personnel are required to participate in follow-up testing as a result of any of the following circumstances:

a. Reinstatement of site access after completion of a rehabilitation program or treatment.

l b. Reporting to the MRO prior fitness for duty i violations under another Fitness for Duty Program.

c. Reinstatement of site access for alcohol related incidents.

6.15.3 The MRO or designee, shall maintain a system of filing, tracking, and recording to include:

a. A file for each individual undergoing the follow-up testing program containing, at a minimum, the following:

1. The appropriate forms for each test.

2. The results of each test.

3. A method of recording results so that they are readily available for reporting requirements (e.g., Semi-Annual Report).

20 7%f t l PACE - REv:StoN PAOCEDURE NU BER DAVIS BESSE ADMINISTRATIVE PROCEDURE i

Drug and Alcohol Testing Process 39 01 IS-AC-00018 7.0 RECORDE 7.1 The following quality assurance records are completed by this procedure and snall be listed on the Nuclear Records List, captured, and submitted to Nuclear Records Management in accordance with NG-IM-00106 (NG-PS-00106). C-1l 7.1.1 Drug Testing Custody & Control Forn l 7.1.2 Permanent Record Book l 7.1.3 Notification of Random Tasting j 7.1.4 Blind Samples I ,

7.1.5 Laboratory Results j 7.1.6 Individual Specimen Collection Documentation l 7.1.7 Consent /For Drug / Alcohol Test / Result Certification ;

7.2 The following non-quality assurance records are completed by this procedure and may be captured and submitted to Nuclear Records Management in accordance with NG-IM-00106 (NG-PS-i 00106). C-1 j 7.2.1 Temperature Record Log 7.2.2 Letter from Prescribing Physician 7.2.3 Good Faith Effort 7.2.4 Retesting Documentation 7.2.5 Monthly Summary I

7.2.6 Training Record Package l 7.2.7 Collection Site Log I 7.2.8 Low Specific Gravities & Creatinine Concontrations Log 7.2.9 Fitness For Duty Authorization  !

7.2.10 Notification of Breath Alcohol Testing C-ll

6....

PAGE REVISION PQOCEDURE NUMBEQ DAVIS-BEISSE ADMINOTRATIVE PROCEDURE Drug and Alcohol Testing Process 40 01 IS-AC-00018 ATTACHMENT 1: COLLECTION __ SITE Log l

w.

E i?l I  !

i

$2 E- 1

- I,

~, ,

w I

t kJ  ;

O

/

$- m: 4 4 m

5 eE

[ k '

l 4

5 /

% %9 >

s * ,

5 1 E

i l

l t

s o Attachment 1 ,

j j page 1 of 1 a e: A J a 4 4 i i & -

. _ ~

l l

I

sonn e s PAGE REVtSION PIOCEDUT.E NUMBER DAVIS BESSE ADMINISTRATIVE PROCEDURE l Drug and Alcohol Testing Process 41 01 IS-AC-00018 ATTACHMENT 2: INDIVIDUAL SPECIMEN COLLECTION DOCUMENTATION INotV100AL SPECIMEN COLLECTION DOCUMENTATION 6 0 taat

• Qe 4,,4g s hamat social sggyniD NO.

C 't Cf C appiCast C COhtRacfCA man f f C (w*t C

• s a 10 C 'tCllS40CE C 04'vf RS Ucthst C OTW A ME ALTH CENTER STAFP REPRESENT &Tlytt PRINT N AME f SION A TU R E QAft l

l l l --

CRific AL STEPS INiit A LS l

l 1 8temove outer garmeits l 2. Checn l0

3. Emoty cocnetsevaivables from ourse into locked con a Aeview paperworn for compieneness

5. A.r:so nanas with water crisy

6. Have individwal sign and date cottle sanois E Complete temper resistant lactis

4. At*is specimen 40 num to c- einer

1. *: I sut requisit

10. Foi OW pti ti recare noon i1- G.v e s its cent I seco to cateroom

12. Start timei . to f 3. D' ace ce spot towel ta Measure te reture

15. 5:ntsamois 16 Accly tamcor resistant lacets 1L Have incividuas initiat 10 lacet atfuso f a s1ae of coetsiaer 18 Have inoividual complete section e of teow sition t9 8' ace aliowot in tamper resistant bag aao seat

20. S gn and daie Da0

21. Have individua sign one date ca0

22. 8temove green ane yellow coaies

23. G..e green copy to individual 24 A!tacn yellow to split with rWooer banc 25, P' ace 1,2. 3 & 8 copies in pocnet wit 9 tamper resistani cog tut l 26. P' ace oss and sotit into locueo reirigerator 2r Cammieie oormen.ni recore

il Attachment 2 l i page 1 of 2 l!

1 1

10 e%?l e PAGE REVi$10N f90C50VRE NUMBEQ DAVIS 8 ESSE ADMINISTRATIVE PROCEDURE Drug and Alcohol Testing Process 42 01 IS-Ac-oools i

I INDIVIDUAL _ SPECIMEN COLLECTION DOCUMENTATION (continued)_

I CfitT1 CAL STEPg IN4fl&LS ALCO SENSOR 11

, c.. e..e .n o s....e, o c min.t e e l 2 Checa secs of Asco Seneer il for tornporeture _

l 3 P+ese See4* eviton to se swee it resse 000 __

l 4 Prose est autton 5 Atteen mouthpiece ,,

6 Instr uct inds.idual to tese breath and blow into mouthosece

? Near en0 of breath, doofess *rees' button sopronsmetely $ e*conde S Aecore rossing and mactano number en oorfrenent record boom j

9 West at least 2 minutes but es more Inan 10 minvise

10. Aeoest test _

11 Recerd reevate 6n permanent record book

?2. See green f or . or 10%

11 If 0 04 notify Security Shift Su v __

es s 14 if reewits are 0.01 0.039

15. secome 8/.C rem st , notif y Security Sh*ft Sw', t /

i 16 VNUSUA T C

i weesta cente, we w ed O vee O No Emeiore se woarvisor nouties O v.e O No

$scurity notiting O vee O No I

l l

i i

Attachment 2 page 2 of 2

DAVIS.8 ESSE ADMINISTRATIVE PFtOCEDURE TAGE r,EVISION PROCEDURE NUMBER Drug and Alcohol Tooting Process 43 01 IS-AC-00018 1 ATTACHMENT 3: FITNESS FOR_ DUTY AUTHORIZATION

, , , , , , , , , , FITNESS FOR DUTY AUTHORIZATION - -

I (print), Soetal Security # fully understand that Cleveland tiectric Illuminating Company / Toledo Edison Company has a program of rancos drug and alcohol testing and that ary urinetblood specimen may be analysed for various drugs including. but not limited to, optates. cocaine, marijuana, asphateetnes and phencycIldine. My signature hereon indicates my written authorisation for the drug and alcohol testitig procedure.

DeLOYER FURPOSE OF CRUC/ALColt0L TEST O fteplacement O Site Access O rAr O Fitness For Du y O mando= 0 0ther- O A R A na r=

. . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. . . . . . . . . . .. . . . . .. . . 0 M n H"Me. .. . . . . .

PICTLitE CINTITICATI2f O CSC/CEI/TED Badga O Drivers License G other Failure to cooperate will be an assumptien of gutit and result in tausediate revocation of unescorted access to the Protected Area. Fs11ure to cooperate with tne urine collection er breath analysis process by refusing to. at a annimum. provide a complete specimen. complete paperwork. Initial specimen labels or refusing to follow the instructions of the Medical $2rvices Personnel.

There shall be no seoming, eating, drinking . . .. . burping f or twenty minutes prior to the alcohol test.

In the event of a positive alcohol test. I (do, do not) vish to voluntarily give a blood sample. I fully understand that by not giving a blood sample it indicates I accept the breath test results.

I aave taken, or am taking the following prescription sr non-prescription drugs within the past 30 days Name of Drug (s) and condition for whic.h takant i

-~ -4==s tih -

- w., -

i .

l +

l Signature lCate t  !

Witness Signature i

I Attachment 3 page 1 of 2

. DAVIS-8 ESSE ADMINISTRATIVE PROCEDURE PAGE r,EVISION ' P10CEDur,E NUMBER l l

Drug and Alcohol Tacting Prococ0 44 01 IS-AC-00018 l ATTACHMENT 3:

FITNESS __FOR_ DUTY AUTHORIZATION _(CONTINUED)

Commenis ,

I t

I l

S & &AN f 3.-_ u i

i i

i 4

1 I

Attachment 3 '

page 2 of 2 n.n l

DAVIS-8 ESSE ADMINISTRAT1VE PROCEDURE PAGE r,EvtslON N.OCEDUTINUMBER '

Drug Cnd. Alcohol TOcting Proccoc 45 01 IS-AC-00018 r

ATTACHMENT _4: NOTIFICATION X RANDOM TESTING ,

4 j

NOTIF.ICATION so sie QF RANDOM ORUG TESTING SECTICN t . h0TIFIC ATION OF TESTshO f I

caig 3 emoiviOwas 44LECTED 5

j

1. Cliflom (WPLQrt R I

P THE INotv10uAL SELECTIC is ASSENT F ACW WCAK ColePLETE SECTicM 3 i mots 4o er iraing , me...

,,g liGnaiwat N ...

80Sif #Cm

,\ {

. in . n ,i . . . i. . . .., i. i. .

i........in..............i..i.,.......<.,.a....a.e w..un C.ni.e .ae er.v*e. . s m.a.. .

anoiviOwas 3(LECTED -(*A8MI me*** gg -

163ma W8E g IN0tviDW AL SMALL REPCRT TO THE, Mt C ITkTiem74m SH StgCN

• A WORpMMENJMN frg insiviGw as 35LiCTIO F M  % I GLS SC.g453 fine Owg TQ N Coup 4Jef Y.07t RTV OFF CJiu[amt peopgnty C .'

. mw cowaam, swetavison  % ,,, ,

J l i

S4ma f w A4 jOATE X /j '

J i

1. 0safioso SQRWARO CQWPLETEC FORW TO ACCESS CONTROL WA#L STOP 4020 SECT:CN 3.NSALTM CENTta f I

f a6se AEPOAf 60 f

,au.u l l*84 SaME P AOncio .a. es - I w.1 - u.i, -i , ,,,, ,

ip h0. NOTIPV ACCESS CohTROL FOR Gut 0ANCE

.i446 tn Csatsa a rrambami ttaint , m.m.,

54=a rw AE i

X t t

usALTwC:Mr R SnALL Rsf AiN somu wifw iwomouAL s PERSoMAL usoiCAL R CcRoS j

l Attachment 4 page 1 of 1 l

l l

so%n * '

PAGli Atv1510N l F AOCEDURf %MBER l DAVIS.CESSE ADMINISTRATIVE PROCEDURE l

Drug and Alcohol Testing Process __

46 01 IS-AC-oools A'M'ACHMENT _5 t DRUG TESTING CUS.TODY &_ CQ1{ TROL FORM i

i SOUTHGATE ,ORUG TESTING CUSTCDY & CONTROL FORMF3w'"'*l 'a :," " .

% m,.,. -.a. m = =..,. = -

m , , o , ~ , . wtvm

-= w

--Y c ... 6,....

io.a.n.a.i . ca ...o r.-. r':-

EH

, , , , , ..... .. ~ mun e,ou .

Ase -= v

.l hur*4e w ,. , ,

g ,,;;-,, imamcr:'stt'.*am . . .1 . ema - %

s

{, , 4 c

g

.g.a., ,,, , g g, 4,g , w r h'* 6 's

$gteCcaeaugg'@,A$*t , ~

4%:, a, ,

As 5 '3TV%he a  ; , *,,~,,, '- '

• • '#'***"*"' E y .-. . m ,a c .

tip*7.,'Q*g h.. - . % .

O' &.E -

j  : .. . .

- m .

.e... _ m.. .. .. T,,.g.,;, ,, , _ , , , ,,,,.,,, ,

,, , Ce*=a****

.== me ai .= c aswe ,

'= *ere==, a. A

• MM M yg f*

%Q1 Q$~m a %vy. ,

• a.. *. - p.-

• • W * "

m"=ris OF Tuahy ta 47 avstasw sv m m inse ctivtD se e m uvan PROvt04 SPtC: MEN DO OR * ' "

gg]sm ca.aua.i n.c S.,,as

= eens POR TESTIM 3 pj amamesas

e. M

4. M we e, ..

US tem 41 Gees

> . W e5 qq

/.. ., .

=

assee one pts. ene ee. ene

/.. l..

m.m he NN 4 N NN M $kk NWM M N OM NO EN $$OC1O h Mk $N $N - - - - -

het teeR t.48*iar.og gegoat egescul hamnese tria 4Ae8980s an agrarsente esem tegusaene 90 eses m_. _ _ _ gag that N samme statshape &#g tot thel Spott*

====e

-,.--.m.., . . . . . . - . - . . . . . . . . . . . .

Attachment 5 page 1 of 1

- - - ' - - - - - - - - . _ _ _ _ _ . _ m___.__ __

i P;octDvat Suunta

~

DAVIS-4 ESSE ADMINISTRATNE PROCEDURE Pact rtvisioN Drug and Alcohol Todting Proccco 47 01 Is-Ac.coote hT*ACllMENT 6 t_1Z)W SPECIPIC GRAVITIES & CREATININE CONCENTRATIOfiS_ Loc

~ "

, 'O i

' 5

• N P P r r N -

i

! In

! l a l i

i i 1

1. I  ![

1 In#

r -

1 ,e n

I

!s

& h

' 1 V"

lll  :-

l !5

!c 3 IR ll' 1 i 4-

"L 5 i

7i 1

L -

i I i l 0m l jE3 '

l l

'  ! i I 4l - ,

! I I  ;  !  ;  !

! j: Attachment 6

! i l l  !;i page 1 of 1 A7 i

,m. n mA

• s .e~. e,

vavio g;*tt AUMirvi'JIRAllVE P7.OCEDURE PtGE ntvisici P:octDvat Nuves.m ]

Drug cnd Alcohol Tosting Process 48 01 Is AC-00018 l 1

ATTACHME!!T_7 '._TEf1PERATURE _ RECORD LOG i

FLAME DATE I TIME TEMPERATURE l l

- - ~

NO I

l N

nam l

l Attachment 7 page 1 of 1

- - - ,- , , - -_ ,7 __ y .. _yy-%.. -.- ,.--%. , .- , , .., --w,

so ists ._

o e FAGE r.tvisiON PIOCEDUCE NUM8(,7 DAVIS 8 ESSE ADMINISTRATIVE PROCEDURE Drug and Alcohol Testing Process 49 01 IS-AC-00018 i ATTACHMENT _8_ BLIND _ SAMPLES I i

I

" 4 l

I

.Em .

I B H w a -

l w m 3 t~

c ~

> 2

$ C m ,

u IC E T  !

C t~

p m 4

= m ,

l l

8 E

l r l E d

2 C

o Attachment 8 l h page 1 of 1 l m__

l l & fo 1 egap i 8 tnemhcattA c -

A l sr E

x 9

l l

l M Y s m e F c m 5

' E n m -

C M Z >

"" Q

• "l' D

m

?

• l

~ ._,

m m 3,

!! n2 l

l l J#[

l

! m E

2 i

I SELPMAS DNILB__:8 TNEMHCATTA 81000-CA-SI 10 94 ssecorP gnitseT lohoclA dna gurD RE8MUN E800ECORP NOISIVER EGAP ERUDECORP EVITAtiTSINIMDA ESSE 8 SIVAD 1797 01

DAVIS 4 ESSE ADMINISTRATIVE PROCEDURE PAGE i KtviSION FC*tDU E NUM8(2 Drug and Alcohol Tcating Procoso 50 01 IS-AC-00018 i ATTACHME!1T 9: ff0TIFICATIOff OF BREATH ALCollOL TESTI!fG C-1 NOTIFICATION OF BREATil ALColf 0L TESTING (llreath dicohol Content)

Alcohol breatn tests shall be delayed 20 minutes IF any source of mouth alcohol (e g.

breath freshenersi or any other substances are ingested (e.g., eating, smoking.

l re gu rptation of stomach contents from vomiting or burping.)

Please indicate if you have done any of the following within the last 20 minutes:

yg,g NJ I I Consumed mouth alcohol (e g., breath fresheners)

] C [

EstartDrank

[ Q Smoked Chewed O O Durped C

Vomited O C Any "yes" answa beervation period prior to the initial BAC tesun g.

When all the answers , and in 'he event of a laidal positive test, a 20 admute observadon period wi red BEFOR4 laitiaung a confirmatory BAC test.

au.icm =aue i.a'=ie me a m o m w harvas soca ucven vuesa j

-i in we  !

Monitored By:

I l Attachment 9

page 1 of 1

{

l I

i

. - - - - - . ~ .

, a DAVIS BiSSE ADMINISTRATIVE PROCEDURE PAGE mtvisioN i P ottovnt Nuusin ]

Drug and Alcohol Tosting Proc 000 51 01

_ IS-AC-00018 COMMITMEliTS C-1 Sectica Referenga Comment _ \ /

6.11 0 15602 10 CFR 26 Blind Performance Specimen testing for TE and CEI Companlos.

i i

h 1

i i

i i

l l

ED

- _ _ - _ - - _ - - - - - - - - - - - - - -